SOUTHPORT, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and services provider for the detection and ...
-- Viral Vector Facility Further Strengthens Vertical Integration of Kite’s Global CAR T-cell Therapy Manufacturing Network, Supports Growing Demand of Company’s Blood Cancer Treatments -- -- Kite is ...
Viral contamination is an inherent risk during the manufacture of biopharmaceutical products. Whether introduced initially from raw materials or later through specific manufacturing operations, ...
Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing Markets and Technologies Through 2030" report has been added to ResearchAndMarkets.com's offering. The global market for viral ...
DUBLIN, Nov. 28, 2019 /PRNewswire/ -- The "Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (3rd Edition), 2019-2030 (Focus on AAV, Adenoviral, Lentiviral, Retroviral, Plasmid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback